Treatment with luteinizing hormone-releasing hormone antagonist SE-75 decreases levels of epidermal growth factor receptor and its mRNA in OV-1063 human epithelial ovarian cancer xenografts in nude mice

W. Shirahige, C. B. Cook, J. Pinski, G. Halmos, R. Nair, A. V. Schally

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Treatment with luteinizing hormone-releasing hormone antagonist SE-75 decreases levels of epidermal growth factor receptor and its mRNA in OV-1063 human epithelial ovarian cancer xenografts in nude mice'. Together they form a unique fingerprint.

Medicine & Life Sciences